Changes in beat-to-beat blood pressure and pulse rate variability following stroke

• Published in: Scientific reports Vol. 13; no. 1; pp. 19245 - 9
• Main Authors: Abiri, Arash, Chou, En-Fan, Shen, Weining, Fisher, Mark J., Khine, Michelle
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 07.11.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 639/166/985; 692/53/2422; 692/617/375/1370; 692/617/375/534; Blood pressure; Blood Pressure - physiology; Cerebrovascular disease; Heart rate; Heart Rate - physiology; Humanities and Social Sciences; Humans; Monitoring, Physiologic; multidisciplinary; Patients; Pilot Projects; Science; Science (multidisciplinary); Sensors; Stroke
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-45479-4

Associations between cerebrovascular disease and impaired autonomic function and cerebrovascular reactivity have led to increased interest in variability of heart rate (HRV) and blood pressure (BPV) following stroke. In this study, beat-to-beat pulse rate variability (PRV) and BPV were measured in clinically stable stroke patients (6 ischemic, 2 hemorrhagic) at least one year after their last cerebrovascular event. Beat-to-beat blood pressure (BP) measurements were collected from subjects while resting in the sitting position for one hour. Compared with healthy controls, stroke patients exhibited significantly greater time-domain (standard deviation, coefficient of variation, average real variability) and normalized high-frequency BPV (all p  < 0.05). Stroke patients also exhibited lower LF:HF ratios than control subjects ( p  = 0.003). No significant differences were observed in PRV between the two groups, suggesting that BPV may be a more sensitive biomarker of cerebrovascular function in long-term post-stroke patients. Given a paucity of existing literature investigating beat-to-beat BPV in clinically stable post-stroke patients long (> 1 year) after their cerebrovascular events, this pilot study can help inform future studies investigating the mechanisms and effects of BPV in stroke. Elucidating this physiology may facilitate long-term patient monitoring and pharmacological management to mitigate the risk for recurrent stroke.